4-Hydroxybutyric Acid
The risk or severity of adverse effects can be increased when Gamma Hydroxybutyric Acid is combined with Thiothixene.
Abiraterone
The serum concentration of Thiothixene can be increased when it is combined with Abiraterone.
Acepromazine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Acepromazine.
Advertisement
Aceprometazine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Aceprometazine.
Alfaxalone
The risk or severity of adverse effects can be increased when Thiothixene is combined with Alfaxalone.
Alfentanil
The risk or severity of adverse effects can be increased when Alfentanil is combined with Thiothixene.
Advertisement
Almotriptan
The risk or severity of adverse effects can be increased when Almotriptan is combined with Thiothixene.
Alphaprodine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Alphaprodine.
Alprazolam
The risk or severity of adverse effects can be increased when Alprazolam is combined with Thiothixene.
Advertisement
Amantadine
The therapeutic efficacy of Thiothixene can be decreased when used in combination with Amantadine.
Amiodarone
Thiothixene may increase the QTc-prolonging activities of Amiodarone.
Amisulpride
Thiothixene may increase the antipsychotic activities of Amisulpride.
Amitriptyline
The risk or severity of adverse effects can be increased when Thiothixene is combined with Amitriptyline.
Amobarbital
The risk or severity of adverse effects can be increased when Amobarbital is combined with Thiothixene.
Amoxapine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Amoxapine.
Amphetamine
Thiothixene may decrease the stimulatory activities of Amphetamine.
Anagrelide
Thiothixene may increase the QTc-prolonging activities of Anagrelide.
Apomorphine
The therapeutic efficacy of Thiothixene can be decreased when used in combination with Apomorphine.
Aripiprazole
The risk or severity of adverse effects can be increased when Aripiprazole is combined with Thiothixene.
Arsenic Trioxide
Thiothixene may increase the QTc-prolonging activities of Arsenic trioxide.
Artemether
Thiothixene may increase the QTc-prolonging activities of Artemether.
Articaine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Articaine.
Asenapine
Thiothixene may increase the QTc-prolonging activities of Asenapine.
Azelastine
Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Azithromycin
The metabolism of Thiothixene can be decreased when combined with Azithromycin.
Baclofen
The risk or severity of adverse effects can be increased when Thiothixene is combined with Baclofen.
Barbital
The risk or severity of adverse effects can be increased when Thiothixene is combined with Barbital.
Bedaquiline
Thiothixene may increase the QTc-prolonging activities of Bedaquiline.
Benoxinate
The risk or severity of adverse effects can be increased when Thiothixene is combined with Oxybuprocaine.
Benperidol
The risk or severity of adverse effects can be increased when Thiothixene is combined with Benperidol.
Benzocaine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Benzocaine.
Benzphetamine
Thiothixene may decrease the stimulatory activities of Benzphetamine.
Benzyl Alcohol
The risk or severity of adverse effects can be increased when Thiothixene is combined with Benzyl alcohol.
Bortezomib
The metabolism of Thiothixene can be decreased when combined with Bortezomib.
Brexpiprazole
The risk or severity of adverse effects can be increased when Thiothixene is combined with Brexpiprazole.
Brimonidine
Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Thiothixene.
Bromazepam
The risk or severity of adverse effects can be increased when Bromazepam is combined with Thiothixene.
Bromocriptine
The therapeutic efficacy of Thiothixene can be decreased when used in combination with Bromocriptine.
Bromperidol
The risk or severity of adverse effects can be increased when Thiothixene is combined with Bromperidol.
Brompheniramine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Brompheniramine.
Brotizolam
The risk or severity of adverse effects can be increased when Thiothixene is combined with Brotizolam.
Bupivacaine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Bupivacaine.
Buprenorphine
Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Buspirone
The risk or severity of adverse effects can be increased when Buspirone is combined with Thiothixene.
Butabarbital
The risk or severity of adverse effects can be increased when Butabarbital is combined with Thiothixene.
Butalbital
The risk or severity of adverse effects can be increased when Thiothixene is combined with Butalbital.
Butamben
The risk or severity of adverse effects can be increased when Thiothixene is combined with Butamben.
Butobarbital
The risk or severity of adverse effects can be increased when Thiothixene is combined with Butethal.
Butorphanol
The risk or severity of adverse effects can be increased when Butorphanol is combined with Thiothixene.
Cabergoline
The risk or severity of adverse effects can be increased when Cabergoline is combined with Thiothixene.
Caffeine
The metabolism of Thiothixene can be decreased when combined with Caffeine.
Carbamazepine
The risk or severity of adverse effects can be increased when Carbamazepine is combined with Thiothixene.
Carbinoxamine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Carbinoxamine.
Carisoprodol
The risk or severity of adverse effects can be increased when Thiothixene is combined with Carisoprodol.
Ceritinib
Thiothixene may increase the QTc-prolonging activities of Ceritinib.
Cetirizine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Cetirizine.
Chloral Hydrate
The risk or severity of adverse effects can be increased when Thiothixene is combined with Chloral hydrate.
Chlordiazepoxide
The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Thiothixene.
Chlormethiazole
The risk or severity of adverse effects can be increased when Thiothixene is combined with clomethiazole.
Chlormezanone
The risk or severity of adverse effects can be increased when Thiothixene is combined with Chlormezanone.
Chloroprocaine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Chloroprocaine.
Chloroquine
Thiothixene may increase the QTc-prolonging activities of Chloroquine.
Chlorpheniramine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Chlorphenamine.
CHLORPHENIRAMINE POLISTIREX
The risk or severity of adverse effects can be increased when Thiothixene is combined with Chlorphenamine.
Chlorpromazine
The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Thiothixene.
Chlorprothixene
The risk or severity of adverse effects can be increased when Thiothixene is combined with Chlorprothixene.
Chlorzoxazone
The risk or severity of adverse effects can be increased when Thiothixene is combined with Chlorzoxazone.
Ciprofloxacin
Thiothixene may increase the QTc-prolonging activities of Ciprofloxacin.
Cisapride
Thiothixene may increase the QTc-prolonging activities of Cisapride.
Citalopram
Thiothixene may increase the QTc-prolonging activities of Citalopram.
Clarithromycin
Thiothixene may increase the QTc-prolonging activities of Clarithromycin.
Clemastine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Clemastine.
Clidinium
The risk or severity of adverse effects can be increased when Thiothixene is combined with Clidinium.
Clidinium bromide
The risk or severity of adverse effects can be increased when Thiothixene is combined with Clidinium.
Clobazam
The risk or severity of adverse effects can be increased when Thiothixene is combined with Clobazam.
Clomipramine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Clomipramine.
Clonazepam
The risk or severity of adverse effects can be increased when Thiothixene is combined with Clonazepam.
Clonidine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Clonidine.
Clorazepate
The risk or severity of adverse effects can be increased when Clorazepate is combined with Thiothixene.
CLORAZEPIC ACID
The risk or severity of adverse effects can be increased when Clorazepate is combined with Thiothixene.
Clotrimazole
The metabolism of Thiothixene can be decreased when combined with Clotrimazole.
Clozapine
The risk or severity of adverse effects can be increased when Clozapine is combined with Thiothixene.
Cocaine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Cocaine.
Codeine
The risk or severity of adverse effects can be increased when Codeine is combined with Thiothixene.
Codeine Anhydrous
The risk or severity of adverse effects can be increased when Codeine is combined with Thiothixene.
CODEINE POLISTIREX
The risk or severity of adverse effects can be increased when Codeine is combined with Thiothixene.
Crizotinib
Thiothixene may increase the QTc-prolonging activities of Crizotinib.
Curcumin
The metabolism of Thiothixene can be decreased when combined with Curcumin.
Cyclizine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Cyclizine.
Cyclobenzaprine
The risk or severity of adverse effects can be increased when Cyclobenzaprine is combined with Thiothixene.
Cyproheptadine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Cyproheptadine.
Cyproterone Acetate
The serum concentration of Thiothixene can be decreased when it is combined with Cyproterone acetate.
Dantrolene
The risk or severity of adverse effects can be increased when Thiothixene is combined with Dantrolene.
Dapiprazole
The risk or severity of adverse effects can be increased when Thiothixene is combined with Dapiprazole.
Deferasirox
The serum concentration of Thiothixene can be increased when it is combined with Deferasirox.
Desflurane
The risk or severity of adverse effects can be increased when Desflurane is combined with Thiothixene.
Desipramine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Desipramine.
Desloratadine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Desloratadine.
Desvenlafaxine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Desvenlafaxine.
Deutetrabenazine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Deutetrabenazine.
Dexbrompheniramine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Dexbrompheniramine.
Dexmedetomidine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Dexmedetomidine.
Dextroamphetamine
Thiothixene may decrease the stimulatory activities of Dextroamphetamine.
Dextromethorphan
The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Thiothixene.
Dextromoramide
The risk or severity of adverse effects can be increased when Thiothixene is combined with Dextromoramide.
Dezocine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Dezocine.
Diazepam
The risk or severity of adverse effects can be increased when Diazepam is combined with Thiothixene.
Dibucaine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Cinchocaine.
Diethylpropion
Thiothixene may decrease the stimulatory activities of Diethylpropion.
Difenoxin
The risk or severity of adverse effects can be increased when Thiothixene is combined with Difenoxin.
Dihydrocodeine
The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Thiothixene.
Dihydroergotamine
The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Thiothixene.
Dimenhydrinate
The risk or severity of adverse effects can be increased when Thiothixene is combined with Dimenhydrinate.
Diphenhydramine
The risk or severity of adverse effects can be increased when Diphenhydramine is combined with Thiothixene.
Diphenoxylate
The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Thiothixene.
Disopyramide
Thiothixene may increase the QTc-prolonging activities of Disopyramide.
Dofetilide
Thiothixene may increase the QTc-prolonging activities of Dofetilide.
Dolasetron
Thiothixene may increase the QTc-prolonging activities of Dolasetron.
Domperidone
Thiothixene may increase the QTc-prolonging activities of Domperidone.
Dothiepin
The metabolism of Thiothixene can be decreased when combined with Dosulepin.
Doxepin
The risk or severity of adverse effects can be increased when Thiothixene is combined with Doxepin.
Doxylamine
Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Thiothixene.
Dronedarone
Thiothixene may increase the QTc-prolonging activities of Dronedarone.
Droperidol
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Thiothixene.
Duloxetine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Duloxetine.
Dyclonine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Dyclonine.
Efavirenz
The risk or severity of adverse effects can be increased when Thiothixene is combined with Efavirenz.
Eletriptan
The risk or severity of adverse effects can be increased when Eletriptan is combined with Thiothixene.
Eliglustat
Thiothixene may increase the QTc-prolonging activities of Eliglustat.
Enflurane
The risk or severity of adverse effects can be increased when Thiothixene is combined with Enflurane.
Entacapone
The risk or severity of adverse effects can be increased when Thiothixene is combined with Entacapone.
ergoloid mesylates, USP
The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Thiothixene.
Ergonovine
The risk or severity of adverse effects can be increased when Ergonovine is combined with Thiothixene.
Ergotamine
The risk or severity of adverse effects can be increased when Ergotamine is combined with Thiothixene.
Erythromycin
Thiothixene may increase the QTc-prolonging activities of Erythromycin.
Escitalopram
Thiothixene may increase the QTc-prolonging activities of Escitalopram.
Estazolam
The risk or severity of adverse effects can be increased when Estazolam is combined with Thiothixene.
Eszopiclone
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Thiothixene.
Ethanol
Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
Ethchlorvynol
The risk or severity of adverse effects can be increased when Thiothixene is combined with Ethchlorvynol.
Ethosuximide
The risk or severity of adverse effects can be increased when Thiothixene is combined with Ethosuximide.
Ethotoin
The risk or severity of adverse effects can be increased when Thiothixene is combined with Ethotoin.
Ethyl Chloride
The risk or severity of adverse effects can be increased when Thiothixene is combined with Ethyl chloride.
Ethyl Loflazepate
The risk or severity of adverse effects can be increased when Thiothixene is combined with Ethyl loflazepate.
Ethylmorphine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Ethylmorphine.
Etidocaine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Etidocaine.
Etifoxine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Etifoxine.
Etomidate
The risk or severity of adverse effects can be increased when Thiothixene is combined with Etomidate.
Ezogabine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Ezogabine.
Felbamate
The risk or severity of adverse effects can be increased when Thiothixene is combined with Felbamate.
Fentanyl
The risk or severity of adverse effects can be increased when Fentanyl is combined with Thiothixene.
Fesoterodine
The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Thiothixene.
Fexofenadine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Fexofenadine.
Flecainide
Thiothixene may increase the QTc-prolonging activities of Flecainide.
Flibanserin
The risk or severity of adverse effects can be increased when Thiothixene is combined with Flibanserin.
Flunarizine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Flunarizine.
Flunitrazepam
The risk or severity of adverse effects can be increased when Thiothixene is combined with Flunitrazepam.
Fluoxetine
Thiothixene may increase the QTc-prolonging activities of Fluoxetine.
Flupenthixol
Thiothixene may increase the QTc-prolonging activities of Flupentixol.
Fluphenazine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Thiothixene.
Flurazepam
The risk or severity of adverse effects can be increased when Flurazepam is combined with Thiothixene.
Fluspirilene
The risk or severity of adverse effects can be increased when Thiothixene is combined with Fluspirilene.
Fluticasone propionate
The risk or severity of adverse effects can be increased when Thiothixene is combined with Fluticasone propionate.
Fluvoxamine
The metabolism of Thiothixene can be decreased when combined with Fluvoxamine.
Fosphenytoin
The risk or severity of adverse effects can be increased when Thiothixene is combined with Fosphenytoin.
Fospropofol
The risk or severity of adverse effects can be increased when Thiothixene is combined with Fospropofol.
Frovatriptan
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Thiothixene.
Gabapentin
The risk or severity of adverse effects can be increased when Gabapentin is combined with Thiothixene.
Gabapentin Enacarbil
The risk or severity of adverse effects can be increased when Thiothixene is combined with Gabapentin Enacarbil.
Gadobenate
Thiothixene may increase the QTc-prolonging activities of Gadobenic acid.
Gemifloxacin
Thiothixene may increase the QTc-prolonging activities of Gemifloxacin.
Gemifloxacin Mesylate
Thiothixene may increase the QTc-prolonging activities of Gemifloxacin.
Glutethimide
The risk or severity of adverse effects can be increased when Thiothixene is combined with Glutethimide.
Goserelin
Thiothixene may increase the QTc-prolonging activities of Goserelin.
Granisetron
Thiothixene may increase the QTc-prolonging activities of Granisetron.
Guanfacine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Guanfacine.
Halazepam
The risk or severity of adverse effects can be increased when Thiothixene is combined with Halazepam.
Haloperidol
The risk or severity of adverse effects can be increased when Haloperidol is combined with Thiothixene.
Halothane
The risk or severity of adverse effects can be increased when Thiothixene is combined with Halothane.
Heroin
The risk or severity of adverse effects can be increased when Thiothixene is combined with Heroin.
Hexobarbital
The risk or severity of adverse effects can be increased when Thiothixene is combined with Hexobarbital.
Hydrocodone
Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
HYDROCODONE POLISTIREX
Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Hydromorphone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Thiothixene.
Hydroxyzine
Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Thiothixene.
Ibutilide
Thiothixene may increase the QTc-prolonging activities of Ibutilide.
Iloperidone
Thiothixene may increase the QTc-prolonging activities of Iloperidone.
Imipramine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Imipramine.
Isocarboxazid
The therapeutic efficacy of Thiothixene can be increased when used in combination with Isocarboxazid.
Isoflurane
The risk or severity of adverse effects can be increased when Isoflurane is combined with Thiothixene.
Ketamine
The risk or severity of adverse effects can be increased when Ketamine is combined with Thiothixene.
Ketazolam
The risk or severity of adverse effects can be increased when Thiothixene is combined with Ketazolam.
Lamotrigine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Lamotrigine.
Lenvatinib
Thiothixene may increase the QTc-prolonging activities of Lenvatinib.
Lenvatinib Mesylate
Thiothixene may increase the QTc-prolonging activities of Lenvatinib.
Leuprolide
Thiothixene may increase the QTc-prolonging activities of Leuprolide.
Levetiracetam
The risk or severity of adverse effects can be increased when Thiothixene is combined with Levetiracetam.
Levobupivacaine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Levobupivacaine.
Levocabastine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Levocabastine.
Levocetirizine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Levocetirizine.
Levodopa
The therapeutic efficacy of Thiothixene can be decreased when used in combination with Levodopa.
Levofloxacin
Thiothixene may increase the QTc-prolonging activities of Levofloxacin.
Levofloxacin Anhydrous
Thiothixene may increase the QTc-prolonging activities of Levofloxacin.
Levomethadyl
The risk or severity of adverse effects can be increased when Thiothixene is combined with Levomethadyl Acetate.
Levomilnacipran
The risk or severity of adverse effects can be increased when Thiothixene is combined with Levomilnacipran.
Levorphanol
The risk or severity of adverse effects can be increased when Levorphanol is combined with Thiothixene.
Lidocaine
The metabolism of Thiothixene can be decreased when combined with Lidocaine.
Linezolid
The risk or severity of adverse effects can be increased when Linezolid is combined with Thiothixene.
Lisdexamfetamine
Thiothixene may decrease the stimulatory activities of Lisdexamfetamine.
Lisdexamfetamine Dimesylate
Thiothixene may decrease the stimulatory activities of Lisdexamfetamine.
Lithium
Lithium may increase the neurotoxic activities of Thiothixene.
Lithium Cation
Lithium may increase the neurotoxic activities of Thiothixene.
Lofexidine
The therapeutic efficacy of Thiothixene can be increased when used in combination with Lofexidine.
Lopinavir
Thiothixene may increase the QTc-prolonging activities of Lopinavir.
Loratadine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Loratadine.
Lorazepam
The risk or severity of adverse effects can be increased when Lorazepam is combined with Thiothixene.
Lorcaserin
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Thiothixene.
Lormetazepam
The risk or severity of adverse effects can be increased when Thiothixene is combined with Lormetazepam.
Loxapine
The risk or severity of adverse effects can be increased when Loxapine is combined with Thiothixene.
Lumefantrine
Thiothixene may increase the QTc-prolonging activities of Lumefantrine.
Lurasidone
The risk or severity of adverse effects can be increased when Thiothixene is combined with Lurasidone.
Magnesium Sulfate
The therapeutic efficacy of Thiothixene can be increased when used in combination with Magnesium sulfate.
MAGNESIUM SULFATE ANHYDROUS
The therapeutic efficacy of Thiothixene can be increased when used in combination with Magnesium sulfate.
Maprotiline
The risk or severity of adverse effects can be increased when Thiothixene is combined with Maprotiline.
Meclizine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Meclizine.
Melatonin
The risk or severity of adverse effects can be increased when Thiothixene is combined with Melatonin.
Meperidine
The risk or severity of adverse effects can be increased when Pethidine is combined with Thiothixene.
Mephentermine
Thiothixene may decrease the stimulatory activities of Mephentermine.
Mephobarbital
The risk or severity of adverse effects can be increased when Thiothixene is combined with Methylphenobarbital.
Mepivacaine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Mepivacaine.
Meprobamate
The risk or severity of adverse effects can be increased when Meprobamate is combined with Thiothixene.
Mequitazine
Thiothixene may increase the arrhythmogenic activities of Mequitazine.
Mesoridazine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Mesoridazine.
Metaxalone
The risk or severity of adverse effects can be increased when Thiothixene is combined with Metaxalone.
Methadone
The risk or severity of adverse effects can be increased when Methadone is combined with Thiothixene.
Methadyl Acetate
The risk or severity of adverse effects can be increased when Thiothixene is combined with Methadyl Acetate.
Methamphetamine
Thiothixene may decrease the stimulatory activities of Methamphetamine.
Methapyrilene
The risk or severity of adverse effects can be increased when Thiothixene is combined with Methapyrilene.
Methaqualone
The risk or severity of adverse effects can be increased when Thiothixene is combined with Methaqualone.
Methocarbamol
The risk or severity of adverse effects can be increased when Thiothixene is combined with Methocarbamol.
Methohexital
The risk or severity of adverse effects can be increased when Methohexital is combined with Thiothixene.
Methotrimeprazine
Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Methoxyflurane
The risk or severity of adverse effects can be increased when Thiothixene is combined with Methoxyflurane.
Methsuximide
The risk or severity of adverse effects can be increased when Thiothixene is combined with Methsuximide.
Methylphenidate
The risk or severity of adverse effects can be increased when Thiothixene is combined with Methylphenidate.
Metoclopramide
The risk or severity of adverse effects can be increased when Metoclopramide is combined with Thiothixene.
Metoprolol
The serum concentration of Metoprolol can be increased when it is combined with Thiothixene.
Metylperon
The risk or severity of adverse effects can be increased when Thiothixene is combined with Melperone.
Metyrosine
Thiothixene may increase the sedative activities of Metyrosine.
Mexiletine
The metabolism of Thiothixene can be decreased when combined with Mexiletine.
Midazolam
The risk or severity of adverse effects can be increased when Midazolam is combined with Thiothixene.
Midostaurin
The metabolism of Thiothixene can be decreased when combined with Midostaurin.
Mifepristone
Mifepristone may increase the QTc-prolonging activities of Thiothixene.
Milnacipran
The risk or severity of adverse effects can be increased when Thiothixene is combined with Milnacipran.
Minocycline
Minocycline may increase the central nervous system depressant (CNS depressant) activities of Thiothixene.
Mirtazapine
Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.
Moclobemide
The risk or severity of adverse effects can be increased when Moclobemide is combined with Thiothixene.
Molindone
The risk or severity of adverse effects can be increased when Thiothixene is combined with Molindone.
Morphine
The risk or severity of adverse effects can be increased when Morphine is combined with Thiothixene.
Moxifloxacin
Thiothixene may increase the QTc-prolonging activities of Moxifloxacin.
Nabilone
Nabilone may increase the central nervous system depressant (CNS depressant) activities of Thiothixene.
Nalbuphine
The risk or severity of adverse effects can be increased when Nalbuphine is combined with Thiothixene.
Naratriptan
The risk or severity of adverse effects can be increased when Naratriptan is combined with Thiothixene.
Nefazodone
The risk or severity of adverse effects can be increased when Thiothixene is combined with Nefazodone.
Nevirapine
The metabolism of Thiothixene can be decreased when combined with Nevirapine.
Nilotinib
Thiothixene may increase the QTc-prolonging activities of Nilotinib.
Nitrazepam
The risk or severity of adverse effects can be increased when Nitrazepam is combined with Thiothixene.
Nitrous Oxide
The risk or severity of adverse effects can be increased when Thiothixene is combined with Nitrous oxide.
Nordazepam
The risk or severity of adverse effects can be increased when Thiothixene is combined with Nordazepam.
Norflurane
The risk or severity of adverse effects can be increased when Thiothixene is combined with Norflurane.
Normethadone
The risk or severity of adverse effects can be increased when Thiothixene is combined with Normethadone.
Nortriptyline
The risk or severity of adverse effects can be increased when Thiothixene is combined with Nortriptyline.
Ofloxacin
Thiothixene may increase the QTc-prolonging activities of Ofloxacin.
Olanzapine
The risk or severity of adverse effects can be increased when Olanzapine is combined with Thiothixene.
Olopatadine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Olopatadine.
Ondansetron
The risk or severity of adverse effects can be increased when Thiothixene is combined with Ondansetron.
Opium
The risk or severity of adverse effects can be increased when Thiothixene is combined with Opium.
Orphenadrine
Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Osimertinib
The serum concentration of Thiothixene can be decreased when it is combined with Osimertinib.
Oxazepam
The risk or severity of adverse effects can be increased when Oxazepam is combined with Thiothixene.
Oxprenolol
The risk or severity of adverse effects can be increased when Thiothixene is combined with Oxprenolol.
Oxycodone
The risk or severity of adverse effects can be increased when Oxycodone is combined with Thiothixene.
Oxymorphone
The risk or severity of adverse effects can be increased when Oxymorphone is combined with Thiothixene.
p-Hydroxyamphetamine
Thiothixene may decrease the stimulatory activities of Hydroxyamphetamine.
Paliperidone
Thiothixene may increase the QTc-prolonging activities of Paliperidone.
Panobinostat
Thiothixene may increase the QTc-prolonging activities of Panobinostat.
Paraldehyde
Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Paregoric
The risk or severity of adverse effects can be increased when Morphine is combined with Thiothixene.
Paroxetine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Paroxetine.
Pazopanib
Thiothixene may increase the QTc-prolonging activities of Pazopanib.
Peginterferon Alfa-2b
The serum concentration of Thiothixene can be increased when it is combined with Peginterferon alfa-2b.
Pentamidine
Thiothixene may increase the QTc-prolonging activities of Pentamidine.
Pentazocine
The risk or severity of adverse effects can be increased when Pentazocine is combined with Thiothixene.
Pentobarbital
The risk or severity of adverse effects can be increased when Pentobarbital is combined with Thiothixene.
Perampanel
Perampanel may increase the central nervous system depressant (CNS depressant) activities of Thiothixene.
Perazine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Perazine.
Perflutren
Thiothixene may increase the QTc-prolonging activities of Perflutren.
Perphenazine
The risk or severity of adverse effects can be increased when Perphenazine is combined with Thiothixene.
Phenelzine
The risk or severity of adverse effects can be increased when Phenelzine is combined with Thiothixene.
Phenobarbital
The risk or severity of adverse effects can be increased when Phenobarbital is combined with Thiothixene.
Phenoxyethanol
The risk or severity of adverse effects can be increased when Thiothixene is combined with Phenoxyethanol.
Phentermine
Thiothixene may decrease the stimulatory activities of Phentermine.
PHENTERMINE RESIN
Thiothixene may decrease the stimulatory activities of Phentermine.
Phenytoin
The risk or severity of adverse effects can be increased when Thiothixene is combined with Phenytoin.
Pimozide
Thiothixene may increase the QTc-prolonging activities of Pimozide.
Pipamperone
The risk or severity of adverse effects can be increased when Thiothixene is combined with Pipamperone.
Pipothiazine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Pipotiazine.
Piribedil
The therapeutic efficacy of Thiothixene can be decreased when used in combination with Piribedil.
Pirinitramide
The risk or severity of adverse effects can be increased when Thiothixene is combined with Piritramide.
Pizotyline
The risk or severity of adverse effects can be increased when Thiothixene is combined with Pizotifen.
Pomalidomide
The risk or severity of adverse effects can be increased when Thiothixene is combined with Pomalidomide.
Pramipexole
Thiothixene may increase the sedative activities of Pramipexole.
Pramoxine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Pramocaine.
Prazepam
The risk or severity of adverse effects can be increased when Thiothixene is combined with Prazepam.
Pregabalin
The therapeutic efficacy of Thiothixene can be increased when used in combination with Pregabalin.
Prilocaine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Prilocaine.
Primaquine
Thiothixene may increase the QTc-prolonging activities of Primaquine.
Primidone
The risk or severity of adverse effects can be increased when Thiothixene is combined with Primidone.
Procainamide
Thiothixene may increase the QTc-prolonging activities of Procainamide.
Procaine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Procaine.
Procarbazine
The risk or severity of adverse effects can be increased when Procarbazine is combined with Thiothixene.
Prochlorperazine
The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Thiothixene.
Promazine
The risk or severity of adverse effects can be increased when Promazine is combined with Thiothixene.
Promethazine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Promethazine.
Propafenone
Thiothixene may increase the QTc-prolonging activities of Propafenone.
Proparacaine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Proparacaine.
Propofol
The risk or severity of adverse effects can be increased when Propofol is combined with Thiothixene.
Propoxyphene
The risk or severity of adverse effects can be increased when Thiothixene is combined with Dextropropoxyphene.
Protriptyline
The risk or severity of adverse effects can be increased when Thiothixene is combined with Protriptyline.
Pseudoephedrine
Thiothixene may decrease the stimulatory activities of Pseudoephedrine.
Quazepam
The risk or severity of adverse effects can be increased when Quazepam is combined with Thiothixene.
Quetiapine
Thiothixene may increase the QTc-prolonging activities of Quetiapine.
Quetiapine fumarate
Thiothixene may increase the QTc-prolonging activities of Quetiapine.
Quinagolide
The therapeutic efficacy of Quinagolide can be decreased when used in combination with Thiothixene.
Quinidine
Thiothixene may increase the QTc-prolonging activities of Quinidine.
Quinine
Thiothixene may increase the QTc-prolonging activities of Quinine.
Ramelteon
The risk or severity of adverse effects can be increased when Thiothixene is combined with Ramelteon.
Rasagiline
The risk or severity of adverse effects can be increased when Rasagiline is combined with Thiothixene.
Remifentanil
The risk or severity of adverse effects can be increased when Remifentanil is combined with Thiothixene.
Remoxipride
The risk or severity of adverse effects can be increased when Thiothixene is combined with Remoxipride.
Reserpine
The risk or severity of adverse effects can be increased when Reserpine is combined with Thiothixene.
Risperidone
The risk or severity of adverse effects can be increased when Risperidone is combined with Thiothixene.
Rizatriptan
The risk or severity of adverse effects can be increased when Rizatriptan is combined with Thiothixene.
Ropinirole
Thiothixene may increase the sedative activities of Ropinirole.
Ropivacaine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Ropivacaine.
Rotigotine
Thiothixene may increase the sedative activities of Rotigotine.
Rucaparib
The metabolism of Thiothixene can be decreased when combined with Rucaparib.
Rufinamide
The risk or severity of adverse effects can be increased when Rufinamide is combined with Thiothixene.
Saquinavir
Thiothixene may increase the QTc-prolonging activities of Saquinavir.
Saquinavir Mesylate
Thiothixene may increase the QTc-prolonging activities of Saquinavir.
Scopolamine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Scopolamine.
Scopolamine Hydrobromide
The risk or severity of adverse effects can be increased when Thiothixene is combined with Scopolamine.
Secobarbital
The risk or severity of adverse effects can be increased when Secobarbital is combined with Thiothixene.
Selegiline
The risk or severity of adverse effects can be increased when Selegiline is combined with Thiothixene.
Sertindole
The risk or severity of adverse effects can be increased when Thiothixene is combined with Sertindole.
Sertraline
The risk or severity of adverse effects can be increased when Thiothixene is combined with Sertraline.
Sevoflurane
The risk or severity of adverse effects can be increased when Sevoflurane is combined with Thiothixene.
Simeprevir
The metabolism of Thiothixene can be decreased when combined with Simeprevir.
Sodium Oxybate
Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Thiothixene.
Sotalol
Thiothixene may increase the QTc-prolonging activities of Sotalol.
Sufentanil
The risk or severity of adverse effects can be increased when Sufentanil is combined with Thiothixene.
Sulfisoxazole
Thiothixene may increase the QTc-prolonging activities of Sulfisoxazole.
Sulpiride
Thiothixene may increase the antipsychotic activities of Sulpiride.
Sumatriptan
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Thiothixene.
Sumatriptan Succinate
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Thiothixene.
Suvorexant
Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Tapentadol
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Thiothixene.
Tasimelteon
The risk or severity of adverse effects can be increased when Thiothixene is combined with Tasimelteon.
Tedizolid
The risk or severity of adverse effects can be increased when Tedizolid Phosphate is combined with Thiothixene.
Tedizolid Phosphate
The risk or severity of adverse effects can be increased when Tedizolid Phosphate is combined with Thiothixene.
Telavancin
Thiothixene may increase the QTc-prolonging activities of Telavancin.
Telithromycin
Thiothixene may increase the QTc-prolonging activities of Telithromycin.
Temazepam
The risk or severity of adverse effects can be increased when Temazepam is combined with Thiothixene.
Tenofovir Disoproxil
The metabolism of Thiothixene can be decreased when combined with Tenofovir disoproxil.
Teriflunomide
The serum concentration of Thiothixene can be decreased when it is combined with Teriflunomide.
Tetrabenazine
The risk or severity of adverse effects can be increased when Tetrabenazine is combined with Thiothixene.
Tetracaine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Tetracaine.
Tetracaine hydrochloride
The risk or severity of adverse effects can be increased when Thiothixene is combined with Tetracaine.
Tetrahydrocannabinol
Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Thiothixene.
Thalidomide
Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Theophylline
The metabolism of Thiothixene can be decreased when combined with Theophylline.
Theophylline anhydrous
The metabolism of Thiothixene can be decreased when combined with Theophylline.
Thiamylal
The risk or severity of adverse effects can be increased when Thiothixene is combined with Thiamylal.
Thiopental
The risk or severity of adverse effects can be increased when Thiothixene is combined with Thiopental.
Thiopental Sodium
The risk or severity of adverse effects can be increased when Thiothixene is combined with Thiopental.
Thioridazine
The serum concentration of Thioridazine can be increased when it is combined with Thiothixene.
Tiagabine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Tiagabine.
Tiapride
The risk or severity of adverse effects can be increased when Thiothixene is combined with Tiapride.
Ticlopidine
The metabolism of Thiothixene can be decreased when combined with Ticlopidine.
Tizanidine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Tizanidine.
Tolcapone
The risk or severity of adverse effects can be increased when Thiothixene is combined with Tolcapone.
Topiramate
The risk or severity of adverse effects can be increased when Thiothixene is combined with Topiramate.
Toremifene
Thiothixene may increase the QTc-prolonging activities of Toremifene.
Tramadol
The risk or severity of adverse effects can be increased when Tramadol is combined with Thiothixene.
Tranylcypromine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Tranylcypromine.
Trazodone
The risk or severity of adverse effects can be increased when Thiothixene is combined with Trazodone.
Triazolam
The risk or severity of adverse effects can be increased when Triazolam is combined with Thiothixene.
Triazulenone
The risk or severity of adverse effects can be increased when Thiothixene is combined with Loprazolam.
Trifluoperazine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Thiothixene.
Triflupromazine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Triflupromazine.
Trimipramine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Trimipramine.
Triprolidine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Triprolidine.
Urethane
The risk or severity of adverse effects can be increased when Thiothixene is combined with Ethyl carbamate.
Valproate
The risk or severity of adverse effects can be increased when Thiothixene is combined with Valproic Acid.
Valproic Acid
The risk or severity of adverse effects can be increased when Thiothixene is combined with Valproic Acid.
Vandetanib
Thiothixene may increase the QTc-prolonging activities of Vandetanib.
Vemurafenib
The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Thiothixene.
Venlafaxine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Venlafaxine.
Vigabatrin
The risk or severity of adverse effects can be increased when Thiothixene is combined with Vigabatrin.
Vilazodone
The risk or severity of adverse effects can be increased when Vilazodone is combined with Thiothixene.
Vortioxetine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Vortioxetine.
Xylazine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Xylazine.
Zaleplon
The risk or severity of adverse effects can be increased when Zaleplon is combined with Thiothixene.
Ziconotide
The risk or severity of adverse effects can be increased when Thiothixene is combined with Ziconotide.
Ziprasidone
Thiothixene may increase the QTc-prolonging activities of Ziprasidone.
Zolmitriptan
The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Thiothixene.
Zolpidem
Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Zonisamide
The risk or severity of adverse effects can be increased when Thiothixene is combined with Zonisamide.
Zopiclone
The risk or severity of adverse effects can be increased when Zopiclone is combined with Thiothixene.
Zotepine
The risk or severity of adverse effects can be increased when Thiothixene is combined with Zotepine.
Zuclopenthixol
Thiothixene may increase the QTc-prolonging activities of Zuclopenthixol.
